Vote Scores
Filings read through

Wave Life Sciences Ltd.: how funds voted at the meeting of 5 Aug 2025

Ticker
WVE
Meeting
Season
year to 30 June 2026
Filers reporting
67
Ballot items
6

67 filers on Form N-PX reported votes at the Wave Life Sciences Ltd. meeting of 5 Aug 2025. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    9 nominees. 96.5% of the reported votes are for. 10 filers withheld from or voted against at least one nominee.

    684 vote records from 35 filers. 0 of the 35 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 17
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    119 vote records from 67 filers. 10 of the 65 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 23 fund families
    • For 21
    • Against 1
    • Split or no vote 1
    • Against management 1
  3. Item 3: Frequency of the say-on-pay vote

    One year: 64 filers. 1-year: 1 filer.

    119 vote records from 67 filers. 0 of the 65 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 23 fund families
    • Split or no vote 23
  4. Item 4: Audit-related items (auditor ratification)

    76 vote records from 35 filers. 0 of the 35 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 17
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    76 vote records from 35 filers. 22 of the 35 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 8
    • Against 9
    • Against management 9
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    152 vote records from 35 filers. 0 of the 35 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 11
    • Split or no vote 6

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Wave Life Sciences Ltd., meeting of 5 Aug 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
Artisan PartnersForSplitNo report
BNY MellonForSplitNo report
DimensionalSplitSplitNo report
EquitableForSplitFor
FidelityForSplitFor
Franklin TempletonForSplitFor
Goldman SachsForSplitFor
InvescoAgainst, against managementSplitFor
John Hancock and ManulifeForSplitNo report
Macquarie and Delaware FundsForSplitFor
MassMutualForSplitFor
Morgan Stanley, Eaton Vance and CalvertForSplitNo report
NationwideForSplitFor
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialForSplitFor
PrincipalForSplitFor
ProShares and ProFundsForSplitFor
T. Rowe PriceForSplitNo report
TransamericaForSplitFor
Victory CapitalForSplitFor
VoyaForSplitFor

Questions

How many filers reported votes at the Wave Life Sciences Ltd. meeting?
67 Form N-PX filers reported votes at the meeting of 5 Aug 2025. On say-on-pay, 10 of 65 filers that marked the item voted against management (15.4%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Wave Life Sciences Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Wave Life Sciences Ltd. with a meeting date within three days of 5 Aug 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .